Candesartan Cilexetil; Hydrochlorothiazide Patent Expiration
Candesartan Cilexetil; Hydrochlorothiazide is Used for treating high blood pressure. It was first introduced by Ani Pharmaceuticals Inc
Candesartan Cilexetil; Hydrochlorothiazide Patents
Given below is the list of patents protecting Candesartan Cilexetil; Hydrochlorothiazide, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Atacand Hct | US5721263 | Pharmaceutical composition for angiotensin II-mediated diseases |
Feb 24, 2015
(Expired) | Ani Pharms |
| Atacand Hct | US5958961 | Pharmaceutical composition for angiotensin II-mediated diseases |
Jun 06, 2014
(Expired) | Ani Pharms |
| Atacand Hct |
US5534534 (Pediatric) | Pharmaceutical compositions for oral use and method of preparing them |
Jan 09, 2014
(Expired) | Ani Pharms |
| Atacand Hct | US5534534 | Pharmaceutical compositions for oral use and method of preparing them |
Jul 09, 2013
(Expired) | Ani Pharms |
| Atacand Hct |
US5196444 (Pediatric) | 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof |
Dec 04, 2012
(Expired) | Ani Pharms |
Candesartan Cilexetil; Hydrochlorothiazide's Family Patents
Explore Our Curated Drug Screens
Candesartan Cilexetil; Hydrochlorothiazide Generic API Manufacturers
Several generic applications have been filed for Candesartan Cilexetil; Hydrochlorothiazide. The first generic version for Candesartan Cilexetil; Hydrochlorothiazide was by Mylan Pharmaceuticals Inc and was approved on Dec 4, 2012. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on Apr 11, 2018.
Given below is the list of companies who have filed for Candesartan Cilexetil; Hydrochlorothiazide generic, along with the locations of their manufacturing plants worldwide.
1. APOTEX INC
Apotex Inc has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Apotex Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 16MG; 12.5MG | tablet | Discontinued | ORAL | N/A | Dec 4, 2012 |
| 32MG; 12.5MG | tablet | Discontinued | ORAL | N/A | Dec 4, 2012 |
| 32MG; 25MG | tablet | Discontinued | ORAL | N/A | Jun 3, 2013 |
Manufacturing Plant Locations New
Apotex Inc's manufacturing plants are situated in 1 country - Canada. Given below are the details of these plant locations as well as the firm names of Apotex Inc as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| Canada |
| |||||||
2. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 32MG; 12.5MG | tablet | Prescription | ORAL | AB | Jun 3, 2013 |
| 16MG; 12.5MG | tablet | Prescription | ORAL | AB | Jun 3, 2013 |
| 32MG; 25MG | tablet | Prescription | ORAL | AB | Jun 3, 2013 |
3. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 16MG; 12.5MG | tablet | Prescription | ORAL | AB | Feb 27, 2015 |
| 32MG; 12.5MG | tablet | Prescription | ORAL | AB | Feb 27, 2015 |
| 32MG; 25MG | tablet | Prescription | ORAL | AB | Feb 27, 2015 |
4. MYLAN
Mylan Pharmaceuticals Inc has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 32MG; 25MG | tablet | Prescription | ORAL | AB | Dec 4, 2012 |
| 16MG; 12.5MG | tablet | Prescription | ORAL | AB | Dec 4, 2012 |
| 32MG; 12.5MG | tablet | Prescription | ORAL | AB | Dec 4, 2012 |
Manufacturing Plant Locations New
Mylan's manufacturing plants are situated in 4 countries - United States, India, Canada, Ireland. Given below are the details of these plant locations as well as the firm names of Mylan as present at those locations.
| Country | City | Firm Name | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||
| India |
| |||||||||||||||||
| Canada |
| |||||||||||||||||
| Ireland |
| |||||||||||||||||
5. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Prinston Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 16MG; 12.5MG | tablet | Prescription | ORAL | AB | Apr 11, 2018 |
| 32MG; 12.5MG | tablet | Prescription | ORAL | AB | Apr 11, 2018 |
| 32MG; 25MG | tablet | Prescription | ORAL | AB | Apr 11, 2018 |
6. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 3 different strengths of generic version for Candesartan Cilexetil; Hydrochlorothiazide. All of these versions come by the name CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 16MG; 12.5MG | tablet | Prescription | ORAL | AB | Nov 27, 2017 |
| 32MG; 12.5MG | tablet | Prescription | ORAL | AB | Nov 27, 2017 |
| 32MG; 25MG | tablet | Prescription | ORAL | AB | Nov 27, 2017 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||||||